These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5018603)

  • 1. Quantitation of platelet aggregation in myeloproliferative disorders.
    Neemeh JA; Bowie EJ; Thompson JH; Didisheim P; Owen CA
    Am J Clin Pathol; 1972 Mar; 57(3):336-47. PubMed ID: 5018603
    [No Abstract]   [Full Text] [Related]  

  • 2. [The platelet defect in myeloproliferative disorder (author's transl)].
    Delobel J
    Nouv Rev Fr Hematol (1978); 1976; 16(3):443-6. PubMed ID: 1012918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo.
    Thomson C; Forbes CD; Prentice CR
    Clin Sci Mol Med; 1973 Oct; 45(4):485-94. PubMed ID: 4751968
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic myeloproliferative disorders: improved platelet aggregation following venesection.
    Boughton BJ
    Br J Haematol; 1978 Aug; 39(4):589-98. PubMed ID: 698130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders.
    Balduini CL; Bertolino G; Noris P; Piletta GC
    Am J Clin Pathol; 1991 Jan; 95(1):82-6. PubMed ID: 1987755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin on epinephrine-induced lipolysis and platelet aggregation in rats.
    Meester WD; Schut GE; Hamp JA; Sekhar NC
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):405-11. PubMed ID: 5074532
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet function abnormalities in the myeloproliferative disorders.
    Adams T; Schutz L; Goldberg L
    Scand J Haematol; 1974; 13(3):215-24. PubMed ID: 4533155
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet aggregometry in Hageman-deficients and in aspirin treated normal subjects.
    Sarji KE; Iatridis PG; Rodman NF; Ferguson JH
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):177-88. PubMed ID: 5030704
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
    Bousser MG; Lecrubier C
    Nouv Presse Med; 1973 Jun; 2(25):1687-92. PubMed ID: 4718537
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormalities of platelet aggregation in chronic myeloproliferative disorders.
    Avram S; Lupu A; Angelescu S; Olteanu N; Mut-Popescu D
    J Cell Mol Med; 2001; 5(1):79-87. PubMed ID: 12067453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the inhibitory effect of some antiaggregating drugs in " vitro".
    Polli EE; Praga C; Cortellaro M; Pogliani E
    Acta Univ Carol Med Monogr; 1972; 53():199-210. PubMed ID: 4670728
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet defects in the myeloproliferative disorders.
    Inceman S; Tangün Y
    Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
    [No Abstract]   [Full Text] [Related]  

  • 13. [A method for the current registration of spontaneous platelet aggregation].
    Jäger W; Kutschera J
    Thromb Diath Haemorrh Suppl; 1973; 55():305-15. PubMed ID: 4804078
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
    Yamamoto K; Sekiguchi E; Takatani O
    Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of ADP-induced platelet aggregation by adrenaline in vivo and its prevention.
    Yamazaki H; Kobayashi I; Sano T; Shimamoto T
    Thromb Diath Haemorrh; 1973 May; 29(2):490-8. PubMed ID: 4762262
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
    Hochhaus A; Mindner K; Ostermann G; Höche D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 4,5-diphenyl-2-bis-(2-hydroxyethyl)aminoxazol (ditazol) on platelet aggregation, adhesiveness and bleeding time.
    Caprino L; Borrelli F; Falchetti R
    Arzneimittelforschung; 1973 Sep; 23(9):1277-83. PubMed ID: 4801220
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of cyclic AMP in platelet function.
    Salzman EW; Weisenberger H
    Adv Cyclic Nucleotide Res; 1972; 1():231-47. PubMed ID: 4353170
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of furosemide on vitro in platelet aggregation by ADP, adrenaline or collagen].
    Vittoria A; Laghi Pasini F; De Gori V; Forconi S; Di Perri T
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1391-6. PubMed ID: 4458728
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action in vitro of isoxsurprine on platelet aggregation induced by ADP, adrenaline and collagen].
    Di Perri T; Forconi S; Vittoria A; Laghi Pasini F; De Gori V
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1385-90. PubMed ID: 4458727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.